Spencer__Lab Profile Banner
Spencer Lab Profile
Spencer Lab

@Spencer__Lab

Followers
16
Following
2
Media
1
Statuses
17

Our long-term goal is to understand the normal functioning of signaling pathways controlling proliferation and to understand how these signals go awry in cancer

University of Colorado Boulder
Joined August 2023
Don't wanna be here? Send us removal request.
@Spencer__Lab
Spencer Lab
2 years
The Spencer Lab has an opening for a postdoc in the area of cell biology, cancer biology, or systems biology! Click below to apply! https://t.co/Vs30KFdzy7
0
0
0
@Spencer__Lab
Spencer Lab
2 years
Our paper on CDK2 inhibition and cell cycle plasticity has been highlighted by the EACR as one of the most interesting and impactful recent publications in cancer research. See the full list here: https://t.co/77vyVx078n… @EACRnews
0
0
0
@CD_AACR
Cancer Discovery
2 years
In the Spotlight from the March issue— A highly anticipated selective therapeutic agent against CDK2: INX-315, by @LotteWatts and Sabrina L Spencer. https://t.co/ium1G8ch8z @CUBoulder
0
4
4
@Spencer__Lab
Spencer Lab
2 years
https://t.co/O2A607jE0J Check out our In the Spotlight article - published today!
0
0
0
@Spencer__Lab
Spencer Lab
2 years
Happy Holidays from the Spencer Lab🎄
0
1
1
@yao_rong5
Yao Rong
2 years
Excited to share some of my PhD work in Spencer lab @lab_spencer355 on the control of proliferation versus quiescence by amino acid signaling! Special thanks to my collaborators @amcdarnell @ksapp17 of the @mvh_lab for making this project possible! ❤️
@CellReports
Cell Reports
2 years
Cells use multiple mechanisms for cell-cycle arrest upon withdrawal of individual amino acids
1
2
15
@scisignal
Science Signaling
2 years
Bands of cancer cell “escapees” allow several types of cancers to tolerate targeted therapies, a detailed subcellular map tracks the path of a signaling protein over time, and more in this week’s issue of #ScienceSignaling. https://t.co/H6CWN87Kic
0
8
38
@scisignal
Science Signaling
2 years
Small groups of “escapee” #cancer cells that mount replication stress responses may enable tumors to tolerate #MAPKInhibitors, shows a new study involving cell lines and spheroids of melanoma, lung, and colon cancers. https://t.co/up60BXRJCd @CUBIOCHEM1
0
1
4
@scisignal
Science Signaling
2 years
Studying an array of cancer cell lines, a team discovers how #cancers often resist targeted therapies that exploit the MAPK pathway, which hints that suppressing stress tolerance might improve clinical responses to these important cancer drugs. @CUBIOCHEM1 https://t.co/VFtGcswyM9
0
2
1
@DamonRunyon
Damon Runyon Cancer Research Foundation
2 years
In light of the critical role postdoctoral scientists play in research and the economic challenges faced in the early stages of their careers, Damon Runyon Cancer Research Foundation is pleased to announce a 15% increase in our Fellowship stipend. More:
1
14
57